Myofibrillar myopathy: Clinical, morphological and genetic studies in 63 patients

Research output: Contribution to journalArticle

208 Citations (Scopus)

Abstract

The term myofibrillar myopathy (MFM) was proposed in 1996 as a non-committal term for a pathological pattern of myofibrillar dissolution associated with accumulation of myofibrillar degradation products and ectopic expression of multiple proteins that include desmin, βB-crystallin (βBC), dystrophin and congophilic amyloid material. Subsequent studies revealed dominant mutations in desmin and βBC in some MFM patients, and clinical differences between kinships. We here review the clinical, structural and genetic features of 63 unrelated patients diagnosed as having MFM at the Mayo Clinic between 1977 and 2003. The age of onset was 54 ± 16 years (mean ± SD). Weakness was both proximal and distal in 77% and proximal only in 13%. Cardiomyopathy was diagnosed in 16%. Electromyography revealed a myopathic pattern associated with abnormal electrical irritability; 13 patients had abnormal nerve conduction studies but four of these had long-standing diabetes. The abnormal muscle fibres are best identified in trichrome-stained sections as harbouring amorphous, granular or pleomorphic hyaline structures, and vacuoles containing membranous material. The hyaline structures are strongly congophilic. Semiquantitative analysis in each case indicates that among the abnormal fibres, an average of 90, 75, 75, 70 and 70% abnormally express myotilin, desmin, βBC, dystrophin and β-amyloid precursor protein, respectively. Therefore, immunostains for these proteins, and especially for myotilin, are useful adjuncts in the diagnosis of MFM. Electron microscopy shows progressive myofibrillar degeneration commencing at the Z-disk, accumulation of degraded filamentous material and entrapment of dislocated membranous organelles in autophagic vacuoles. In all patients, we searched for mutations in desmin and βBC, as well as in telethonin, a Z-disk-associated protein, or in syncoilin, which together with plectin links desmin to the Z-disk. Two of the 63 patients carry truncation mutations in the C-terminal domain of βBC, four carry missense mutations in the head or tail region of desmin, and none carries a mutation in syncoilin or telethonin. Thus, MFM is morphologically distinct but genetically heterogeneous. Further advances in defining the molecular causes of MFM will probably come from linkage studies of informative kinships or from systematic search for mutations in proteins participating in the intricate network supporting the Z-disk.

Original languageEnglish (US)
Pages (from-to)439-451
Number of pages13
JournalBrain
Volume127
Issue number2
DOIs
StatePublished - Feb 2004

Fingerprint

Desmin
Crystallins
Mutation
Dystrophin
Hyalin
Vacuoles
Proteins
Plectin
Amyloid beta-Protein Precursor
Neural Conduction
Electromyography
Missense Mutation
Cardiomyopathies
Age of Onset
Amyloid
Organelles
Myofibrillar Myopathy
Electron Microscopy
Head
Muscles

Keywords

  • βB-crystallin
  • Desmin
  • Mutation analysis
  • Myofibrillar myopathy
  • Z-disk

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Myofibrillar myopathy : Clinical, morphological and genetic studies in 63 patients. / Selcen, Duygu; Ohno, Kinji; Engel, Andrew G.

In: Brain, Vol. 127, No. 2, 02.2004, p. 439-451.

Research output: Contribution to journalArticle

@article{f81c0f9a925a4234a5d8daa41d2915f5,
title = "Myofibrillar myopathy: Clinical, morphological and genetic studies in 63 patients",
abstract = "The term myofibrillar myopathy (MFM) was proposed in 1996 as a non-committal term for a pathological pattern of myofibrillar dissolution associated with accumulation of myofibrillar degradation products and ectopic expression of multiple proteins that include desmin, βB-crystallin (βBC), dystrophin and congophilic amyloid material. Subsequent studies revealed dominant mutations in desmin and βBC in some MFM patients, and clinical differences between kinships. We here review the clinical, structural and genetic features of 63 unrelated patients diagnosed as having MFM at the Mayo Clinic between 1977 and 2003. The age of onset was 54 ± 16 years (mean ± SD). Weakness was both proximal and distal in 77{\%} and proximal only in 13{\%}. Cardiomyopathy was diagnosed in 16{\%}. Electromyography revealed a myopathic pattern associated with abnormal electrical irritability; 13 patients had abnormal nerve conduction studies but four of these had long-standing diabetes. The abnormal muscle fibres are best identified in trichrome-stained sections as harbouring amorphous, granular or pleomorphic hyaline structures, and vacuoles containing membranous material. The hyaline structures are strongly congophilic. Semiquantitative analysis in each case indicates that among the abnormal fibres, an average of 90, 75, 75, 70 and 70{\%} abnormally express myotilin, desmin, βBC, dystrophin and β-amyloid precursor protein, respectively. Therefore, immunostains for these proteins, and especially for myotilin, are useful adjuncts in the diagnosis of MFM. Electron microscopy shows progressive myofibrillar degeneration commencing at the Z-disk, accumulation of degraded filamentous material and entrapment of dislocated membranous organelles in autophagic vacuoles. In all patients, we searched for mutations in desmin and βBC, as well as in telethonin, a Z-disk-associated protein, or in syncoilin, which together with plectin links desmin to the Z-disk. Two of the 63 patients carry truncation mutations in the C-terminal domain of βBC, four carry missense mutations in the head or tail region of desmin, and none carries a mutation in syncoilin or telethonin. Thus, MFM is morphologically distinct but genetically heterogeneous. Further advances in defining the molecular causes of MFM will probably come from linkage studies of informative kinships or from systematic search for mutations in proteins participating in the intricate network supporting the Z-disk.",
keywords = "βB-crystallin, Desmin, Mutation analysis, Myofibrillar myopathy, Z-disk",
author = "Duygu Selcen and Kinji Ohno and Engel, {Andrew G}",
year = "2004",
month = "2",
doi = "10.1093/brain/awh052",
language = "English (US)",
volume = "127",
pages = "439--451",
journal = "Brain",
issn = "0006-8950",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - Myofibrillar myopathy

T2 - Clinical, morphological and genetic studies in 63 patients

AU - Selcen, Duygu

AU - Ohno, Kinji

AU - Engel, Andrew G

PY - 2004/2

Y1 - 2004/2

N2 - The term myofibrillar myopathy (MFM) was proposed in 1996 as a non-committal term for a pathological pattern of myofibrillar dissolution associated with accumulation of myofibrillar degradation products and ectopic expression of multiple proteins that include desmin, βB-crystallin (βBC), dystrophin and congophilic amyloid material. Subsequent studies revealed dominant mutations in desmin and βBC in some MFM patients, and clinical differences between kinships. We here review the clinical, structural and genetic features of 63 unrelated patients diagnosed as having MFM at the Mayo Clinic between 1977 and 2003. The age of onset was 54 ± 16 years (mean ± SD). Weakness was both proximal and distal in 77% and proximal only in 13%. Cardiomyopathy was diagnosed in 16%. Electromyography revealed a myopathic pattern associated with abnormal electrical irritability; 13 patients had abnormal nerve conduction studies but four of these had long-standing diabetes. The abnormal muscle fibres are best identified in trichrome-stained sections as harbouring amorphous, granular or pleomorphic hyaline structures, and vacuoles containing membranous material. The hyaline structures are strongly congophilic. Semiquantitative analysis in each case indicates that among the abnormal fibres, an average of 90, 75, 75, 70 and 70% abnormally express myotilin, desmin, βBC, dystrophin and β-amyloid precursor protein, respectively. Therefore, immunostains for these proteins, and especially for myotilin, are useful adjuncts in the diagnosis of MFM. Electron microscopy shows progressive myofibrillar degeneration commencing at the Z-disk, accumulation of degraded filamentous material and entrapment of dislocated membranous organelles in autophagic vacuoles. In all patients, we searched for mutations in desmin and βBC, as well as in telethonin, a Z-disk-associated protein, or in syncoilin, which together with plectin links desmin to the Z-disk. Two of the 63 patients carry truncation mutations in the C-terminal domain of βBC, four carry missense mutations in the head or tail region of desmin, and none carries a mutation in syncoilin or telethonin. Thus, MFM is morphologically distinct but genetically heterogeneous. Further advances in defining the molecular causes of MFM will probably come from linkage studies of informative kinships or from systematic search for mutations in proteins participating in the intricate network supporting the Z-disk.

AB - The term myofibrillar myopathy (MFM) was proposed in 1996 as a non-committal term for a pathological pattern of myofibrillar dissolution associated with accumulation of myofibrillar degradation products and ectopic expression of multiple proteins that include desmin, βB-crystallin (βBC), dystrophin and congophilic amyloid material. Subsequent studies revealed dominant mutations in desmin and βBC in some MFM patients, and clinical differences between kinships. We here review the clinical, structural and genetic features of 63 unrelated patients diagnosed as having MFM at the Mayo Clinic between 1977 and 2003. The age of onset was 54 ± 16 years (mean ± SD). Weakness was both proximal and distal in 77% and proximal only in 13%. Cardiomyopathy was diagnosed in 16%. Electromyography revealed a myopathic pattern associated with abnormal electrical irritability; 13 patients had abnormal nerve conduction studies but four of these had long-standing diabetes. The abnormal muscle fibres are best identified in trichrome-stained sections as harbouring amorphous, granular or pleomorphic hyaline structures, and vacuoles containing membranous material. The hyaline structures are strongly congophilic. Semiquantitative analysis in each case indicates that among the abnormal fibres, an average of 90, 75, 75, 70 and 70% abnormally express myotilin, desmin, βBC, dystrophin and β-amyloid precursor protein, respectively. Therefore, immunostains for these proteins, and especially for myotilin, are useful adjuncts in the diagnosis of MFM. Electron microscopy shows progressive myofibrillar degeneration commencing at the Z-disk, accumulation of degraded filamentous material and entrapment of dislocated membranous organelles in autophagic vacuoles. In all patients, we searched for mutations in desmin and βBC, as well as in telethonin, a Z-disk-associated protein, or in syncoilin, which together with plectin links desmin to the Z-disk. Two of the 63 patients carry truncation mutations in the C-terminal domain of βBC, four carry missense mutations in the head or tail region of desmin, and none carries a mutation in syncoilin or telethonin. Thus, MFM is morphologically distinct but genetically heterogeneous. Further advances in defining the molecular causes of MFM will probably come from linkage studies of informative kinships or from systematic search for mutations in proteins participating in the intricate network supporting the Z-disk.

KW - βB-crystallin

KW - Desmin

KW - Mutation analysis

KW - Myofibrillar myopathy

KW - Z-disk

UR - http://www.scopus.com/inward/record.url?scp=0742305818&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0742305818&partnerID=8YFLogxK

U2 - 10.1093/brain/awh052

DO - 10.1093/brain/awh052

M3 - Article

C2 - 14711882

AN - SCOPUS:0742305818

VL - 127

SP - 439

EP - 451

JO - Brain

JF - Brain

SN - 0006-8950

IS - 2

ER -